Inhibition of noroviruses by piperazine derivatives.
Dengfeng Dou, Guijia He, Sivakoteswara Rao Mandadapu, Sridhar Aravapalli, Yunjeong Kim, Kyeong-Ok Chang, William C Groutas
Index: Bioorg. Med. Chem. Lett. 22(1) , 377-9, (2012)
Full Text: HTML
Abstract
There is currently an unmet need for the development of small-molecule therapeutics for norovirus infection. The piperazine scaffold, a privileged structure embodied in many pharmacological agents, was used to synthesize an array of structurally-diverse derivatives which were screened for anti-norovius activity in a cell-based replicon system. The studies described herein demonstrate for the first time that functionalized piperazine derivatives possess anti-norovirus activity. Furthermore, these studies have led to the identification of two promising compounds (6a and 9l) that can be used as a launching pad for the optimization of potency, cytotoxicity, and drug-like characteristics.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2014-04-01
[J. Enzyme Inhib. Med. Chem. , (2013)]
2004-06-07
[Bioorg. Med. Chem. Lett. 14 , 2857-2862, (2004)]
2006-10-13
[J. Org. Chem. 71 , 8283, (2006)]
2004-05-20
[J. Med. Chem. 47 , 2833-2838, (2004)]
Efficient copper-catalyzed cross-coupling of 1-Boc-piperazine with aryl iodides and its application in the synthesis of trazodone. Yong FF, et al.
[Tetrahedron Lett. 54(39) , 5332-34, (2013)]